Nippon Shinyaku Co., Ltd. (TYO:4516)

Japan · Delayed Price · Currency is JPY

3,518.00

+95.00 (2.78%)

Aug 4, 2026, 10:05 AM JST

6.51% (1Y)

Market Cap	230.71B +5.8%
Revenue (ttm)	170.77B +6.6%
Net Income	29.71B -8.7%
EPS	441.00 -8.7%
Shares Out	67.40M
PE Ratio	7.76
Forward PE	7.66
Dividend	124.00 (3.65%)
Ex-Dividend Date	Sep 29, 2026

Volume	179,400
Open	3,446.00
Previous Close	3,423.00
Day's Range	3,437.00 - 3,519.00
52-Week Range	3,075.00 - 6,529.00
Beta	-0.33
Analysts	Hold
Price Target	4,318.75 (+22.76%)
Earnings Date	Aug 6, 2026

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leb... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1911

Employees 2,309

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4516

Full Company Profile

Financial Performance

In fiscal year 2026, Nippon Shinyaku's revenue was 170.77 billion, an increase of 6.58% compared to the previous year's 160.23 billion. Earnings were 29.71 billion, a decrease of -8.76%.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for 4516 stock is "Hold." The 12-month stock price target is ¥4,319, which is an increase of 22.76% from the latest price.

Price Target

¥4,319

(22.76% upside)

Analyst Consensus: Hold

Stock Forecasts